Otorhinolaryngology-Head & Neck Surgery
16 S. Eutaw Street University of Maryland Medical Center Baltimore, MD 21201
Education and Training
University of Virginia, B.A., Economics 2006
University of Maryland School of Medicine, 2010
University of Pennsylvania, Residency: Otorhinolaryngology – Head & Neck Surgery, 2015
University of Pennsylvania, Fellowship: Head & Neck Oncology, Microvascular Reconstruction, and Robotic Surgery, 2016
Dr. Kyle Hatten is the Director of Robotic Surgery in the Department of Otorhinolaryngology - Head & Neck Surgery and Director of the Multi-Disciplinary Head & Neck Cancer Program at the University of Maryland Greenebaum Comprehensive Cancer Center. A graduate of the University of Maryland School of Medicine, Dr. Hatten went onto complete his residency in Otolaryngology – Head and Neck Surgery at the University of Pennsylvania. He continued his surgical training at the University of Pennsylvania by completing a fellowship in head and neck oncology, microvascular reconstruction, and robotic surgery.
Dr. Hatten’s is board certified in Otorhinolaryngology is a fellow of the American Head & Neck Society. His areas of expertise include the surgical management of malignant and benign tumors of the head and neck including cancers of the oral cavity, pharynx, and larynx; tumors of the paranasal sinuses; tumors of the salivary glands; and cutaneous malignancies including melanoma of the head and neck. Dr. Hatten is trained to perform open and endoscopic approaches for treatment of tumors of the skull base as well as complex reconstruction of head and neck defects using microvascular free flap techniques.
Dr. Hatten is actively involved in research focused on head and neck clinical trials, human papillomavirus-associated oropharyngeal cancer, and quality of life outcomes after surgical treatment.
TORS, Robotic, Head & Neck Surgery, Microvascular Reconstruction, Carcinoma of Unknown Primary
Hatten K, Amin J, Isaiah A. Machine learning prediction of extracapsular extension in Human Papillomavirus-associated oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2020. Jun
Gupta N, Strome SE, Hatten K. Is routine genetic testing warranted in head and neck paragangliomas? Laryngoscope. 2019 Jul; 129(7):1491-1493
Hatten, K, Brody, R., Weinstein, G., Newman, J., Bur, A., Chalian, A., O’Malley, B., Rassekh, C., Cannady, S. Defining the Role of Free Flaps for Transoral Robotic Surgery. Annals of Plastic Surgery. 2018, Jan; 80(1): 45-49
Hatten, K., O’Malley BW Jr., Bur AM, Patel M., Rassekh, C., Newman, J., Cannady, S., Chalian, A., Hodnett, B., Lin, A., Lukens, J., Cohen, R., Bauml, J., Montone, K., Livolsi, V., Weinstein, G. Transoral Robotic Surgery-Assited Endoscopy with Primary Site Detection and Treatment in Occult Mucosal Primaries. JAMA Otolaryngol Head Neck Surg. 2016, Dec. PubMed PMID:27930761
Cannady, S., Hatten, K., Bur, A., Brant, J., Fischer, J., Newman, J., Chalian A. Use of free tissue transfer in head and neck cancer surgery and risk of overall and serious complication(s): An American College of Surgeons-National Surgical Quality Improvement Project analysis of free tissue transfer to the head and neck. Head & Neck. 2016, Dec. PubMed PMID:28000297
Hatten, K., Gupta, N., Strome, S. What additional treatment is indicated for oral cavity cancer with isolated perineural invasion? Laryngoscope. 2017. Sept. 127(9): 1965-1966